| Literature DB >> 32312255 |
Yu Fu1, E Andrea Nelson2, Linda McGowan3.
Abstract
BACKGROUND: Urinary incontinence (UI) is a distressing condition that limits women's quality of life and places a heavy burden on health care services. Behavioural treatments are recommended as a first-line treatment. An evidence-based self-management package was developed following the Medical Research Council (MRC) framework for complex interventions. This study aimed to evaluate the feasibility and acceptability of the intervention.Entities:
Keywords: Acceptability; Feasibility; Mixed methods; Randomised controlled trial; Self-management; Urinary incontinence
Mesh:
Year: 2020 PMID: 32312255 PMCID: PMC7171836 DOI: 10.1186/s12894-020-00603-8
Source DB: PubMed Journal: BMC Urol ISSN: 1471-2490 Impact factor: 2.264
Baseline demographics and characteristics
| Variable | Overall | Intervention group | Control group | ||||
|---|---|---|---|---|---|---|---|
| % | % | % | |||||
| Total | 49 | 24 | 25 | ||||
| Age (Mean, SD) | 69.7 | 9.1 | 69.5 | 8.9 | 69.6 | 9.6 | 0.994 |
| Ethnicity | 0.157 | ||||||
| White British | 38 | 77.6% | 16 | 66.7% | 22 | 88.0% | |
| Asian Indian | 9 | 18.4% | 7 | 29.2% | 2 | 8.0% | |
| Mixed White and Black African | 2 | 4.1% | 1 | 4.2% | 1 | 4.0% | |
| Education | 0.486 | ||||||
| Primary | 4 | 8.2% | 3 | 12.5% | 1 | 4.0% | |
| Secondary | 16 | 32.7% | 9 | 37.5% | 7 | 28.0% | |
| Further | 14 | 28.6% | 5 | 20.8% | 9 | 36.0% | |
| Higher | 15 | 30.6% | 7 | 29.2% | 8 | 32.0% | |
| Religion | 0.108 | ||||||
| No religion | 9 | 18.4% | 5 | 20.8% | 4 | 16.0% | |
| Christian | 31 | 63.3% | 12 | 50.0% | 19 | 76.0% | |
| Hindu | 9 | 18.4% | 7 | 29.2% | 2 | 8.0% | |
| Marital status | 0.365 | ||||||
| Single | 6 | 12.2% | 3 | 12.5% | 3 | 12.0% | |
| Married | 27 | 55.1% | 15 | 62.5% | 12 | 48.0% | |
| Separated | 1 | 2.0% | 0 | 0.0% | 1 | 4.0% | |
| Divorced | 3 | 6.1% | 0 | 0.0% | 3 | 12.0% | |
| Widowed | 12 | 24.5% | 6 | 25.0% | 6 | 24.0% | |
| Employment | 0.573 | ||||||
| Full time employed | 3 | 6.1% | 1 | 4.2% | 2 | 8.0% | |
| Part time employed | 5 | 10.2% | 3 | 12.5% | 2 | 8.0% | |
| Self employed | 1 | 2.0% | 0 | 0.0% | 1 | 4.0% | |
| Not in paid employment | 2 | 4.1% | 1 | 4.2% | 1 | 4.0% | |
| Unemployed-looking for work | 1 | 2.0% | 0 | 0.0% | 1 | 4.0% | |
| Retired | 35 | 71.4% | 19 | 79.2% | 16 | 64.0% | |
| Unable to work | 2 | 4.1% | 0 | 0.0% | 2 | 8.0% | |
| Children | 0.421 | ||||||
| None | 11 | 22.4% | 5 | 20.8% | 6 | 24.0% | |
| 1 | 3 | 6.1% | 1 | 4.2% | 2 | 8.0% | |
| 2 | 18 | 36.7% | 9 | 37.5% | 9 | 36.0% | |
| 3 | 11 | 22.4% | 4 | 16.7% | 7 | 28.0% | |
| UI type | 0.672 | ||||||
| Stress UI | 14 | 28.6% | 8 | 33.3% | 6 | 24.0% | |
| Urge UI | 17 | 34.7% | 7 | 29.2% | 10 | 40.0% | |
| Mixed UI | 18 | 36.7% | 9 | 37.5% | 9 | 36.0% | |
| Frequency of UI (average per day) | 0.070 | ||||||
| None | 16 | 32.7% | 12 | 50.0% | 4 | 16.0% | |
| 1 | 8 | 16.3% | 3 | 12.5% | 5 | 20.0% | |
| 2 | 5 | 10.2% | 1 | 4.2% | 4 | 16.0% | |
| 3 | 9 | 18.4% | 5 | 20.8% | 4 | 16.0% | |
| 4+ | 11 | 22.4% | 3 | 12.5% | 8 | 32.0% | |
UI urinary incontinence
Median, interquartile range (IQR), mean, standard deviation (SD) and p-values of outcome measurements at baseline
| Variable | Dimensions | Intervention group | Control group | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| % | Median | IQR | Mean | SD | % | Median | IQR | Mean | SD | |||||
| EQ-5D-5L | Mobility | 0.675 | ||||||||||||
| No/slight problem | 18 | 75.0% | 20 | 80.0% | ||||||||||
| Moderate/Severe/extreme problem | 6 | 25.0% | 5 | 20.0% | ||||||||||
| Selfcare | 0.527 | |||||||||||||
| No/slight problem | 22 | 91.7% | 24 | 96.0% | ||||||||||
| Moderate/Severe/extreme problem | 2 | 8.3% | 1 | 4.0% | ||||||||||
| Usual activities | 0.662 | |||||||||||||
| No/slight problem | 19 | 79.2% | 21 | 84.0% | ||||||||||
| Moderate/Severe/extreme problem | 5 | 20.8% | 4 | 16.0% | ||||||||||
| Pain & discomfort | 0.315 | |||||||||||||
| No/slight problem | 14 | 58.3% | 18 | 72.0% | ||||||||||
| Moderate/Severe/extreme problem | 10 | 41.7% | 7 | 28.0% | ||||||||||
| Anxiety & depression | 0.524 | |||||||||||||
| No/slight problem | 20 | 83.3% | 19 | 76.0% | ||||||||||
| Moderate/Severe/extreme problem | 4 | 16.7% | 6 | 24.0% | ||||||||||
| Index | 24 | 0.90 | 0.23 | 0.82 | 0.17 | 25 | 0.83 | 0.14 | 0.79 | 0.19 | 0.643 | |||
| VAS | 24 | 77.50 | 27.50 | 71.67 | 18.04 | 25 | 70.00 | 25.00 | 64.40 | 25.59 | 0.258 | |||
| KHQ | Part I | |||||||||||||
| General health perception (0-100) | 24 | 25.00 | 25.00 | 33.33 | 21.70 | 25 | 25.00 | 25.00 | 32.00 | 15.34 | 0.804 | |||
| Incontinence impact (0-100) | 24 | 33.33 | 33.33 | 45.83 | 23.70 | 24 | 66.67 | 33.33 | 56.94 | 20.80 | 0.091 | |||
| Part II | ||||||||||||||
| Role limitations (0-100) | 24 | 16.67 | 33.33 | 20.14 | 22.51 | 25 | 33.33 | 33.33 | 33.33 | 24.06 | 0.054 | |||
| Physical limitations (0-100) | 24 | 16.67 | 41.67 | 22.92 | 22.42 | 25 | 33.33 | 33.33 | 30.67 | 20.79 | 0.216 | |||
| Social limitations (0-100) | 24 | 0.00 | 13.89 | 9.03 | 13.19 | 25 | 0.00 | 22.22 | 16.44 | 24.40 | 0.195 | |||
| Personal relationships (0-100) | 15 | 0.00 | 0.00 | 5.56 | 12.06 | 14 | 0.00 | 0.00 | 11.90 | 25.68 | 0.396 | |||
| Emotions (0-100) | 24 | 11.11 | 22.22 | 16.67 | 19.93 | 24 | 11.11 | 11.11 | 17.59 | 14.98 | 0.856 | |||
| Sleep/energy (0-100) | 24 | 33.33 | 41.67 | 37.50 | 28.34 | 25 | 50.00 | 50.00 | 47.33 | 32.16 | 0.263 | |||
| Severity measures (0-100) | 24 | 33.33 | 29.17 | 34.03 | 22.10 | 25 | 41.67 | 33.33 | 48.67 | 22.91 | ||||
| Part III | ||||||||||||||
| Symptom severity scale (0-30) | 24 | 7.50 | 5.50 | 8.00 | 4.39 | 25 | 10.00 | 3.00 | 9.92 | 4.06 | 0.119 | |||
| ICIQ-UI SF | Scale (0-21) | 24 | 8.00 | 6.50 | 8.63 | 4.03 | 25 | 9.00 | 6.00 | 9.68 | 4.19 | 0.374 | ||
| GSE-UI | Scale (0-120) | 24 | 84.50 | 33.50 | 84.96 | 18.89 | 25 | 55.00 | 23.00 | 57.76 | 23.55 | |||
| HADS | Anxiety scale (0-21) | 24 | 6.50 | 6.50 | 7.13 | 5.12 | 25 | 7.00 | 5.00 | 7.56 | 4.56 | 0.755 | ||
| Normal | 13 | 54.2% | 13 | 52.0% | 0.868 | |||||||||
| Mild | 7 | 29.2% | 6 | 24.0% | ||||||||||
| Moderate | 2 | 8.3% | 4 | 16.0% | ||||||||||
| Severe | 2 | 8.3% | 2 | 8.0% | ||||||||||
| Depression scale (0-21) | 24 | 3.00 | 3.50 | 3.67 | 3.29 | 25 | 3.00 | 4.00 | 3.88 | 4.02 | 0.840 | |||
| Normal | 20 | 83.3% | 23 | 92.0% | 0.318 | |||||||||
| Mild | 2 | 8.3% | 0 | 0.0% | ||||||||||
| Moderate | 2 | 8.3% | 1 | 4.0% | ||||||||||
| Severe | 0 | 0 | ||||||||||||
T-tests for continuous variables and chi-square tests for categorical variablesVAS Visual Analogue Scale, KHQ King’s Health Questionnaire, ICIQ-UI SF International Consultation on Incontinence Questionnaire – urinary incontinence short form, GSE-UI Geriatric Self-Efficacy index for urinary incontinence, HADS Hospital Anxiety and Depression Scale
Median, interquartile range (IQR), mean, standard deviation (SD) and p-values of outcome measurements at 12-week follow up
| Variable | Dimensions | Intervention group | Control group | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| % | Median | IQR | Mean | SD | % | Median | IQR | Mean | SD | |||||
| EQ-5D-5L | Mobility | 0.478 | ||||||||||||
| No/slight problem | 21 | 87.5% | 20 | 80.0% | ||||||||||
| Moderate/Severe/extreme problem | 3 | 12.5% | 5 | 20.0% | ||||||||||
| Selfcare | 0.322 | |||||||||||||
| No/slight problem | 24 | 100.0% | 24 | 96.0% | ||||||||||
| Moderate/Severe/extreme problem | 0 | 0.0% | 1 | 4.0% | ||||||||||
| Usual activities | 0.950 | |||||||||||||
| No/slight problem | 20 | 83.3% | 21 | 84.0% | ||||||||||
| Moderate/Severe/extreme problem | 4 | 16.7% | 4 | 16.0% | ||||||||||
| Pain & discomfort | 0.682 | |||||||||||||
| No/slight problem | 17 | 70.8% | 19 | 76.0% | ||||||||||
| Moderate/Severe/extreme problem | 7 | 29.2% | 6 | 24.0% | ||||||||||
| Anxiety & depression | 0.957 | |||||||||||||
| No/slight problem | 21 | 87.5% | 22 | 88.0% | ||||||||||
| Moderate/Severe/extreme problem | 3 | 12.5% | 3 | 12.0% | ||||||||||
| Index | 24 | 0.92 | 0.26 | 0.86 | 0.16 | 25 | 0.88 | 0.16 | 0.83 | 0.19 | 0.471 | |||
| VAS | 24 | 80.00 | 20.00 | 78.54 | 17.60 | 25 | 75.00 | 15.00 | 73.00 | 14.93 | 0.240 | |||
| KHQ | Part I | |||||||||||||
| General health perception (0-100) | 24 | 25.00 | 12.50 | 30.21 | 23.29 | 25 | 25.00 | 25.00 | 31.00 | 20.77 | 0.900 | |||
| Incontinence impact (0-100) | 24 | 33.33 | 33.33 | 45.83 | 21.56 | 25 | 33.33 | 33.33 | 49.33 | 25.68 | 0.609 | |||
| Part II | ||||||||||||||
| Role limitations (0-100) | 24 | 16.67 | 33.33 | 20.14 | 23.04 | 25 | 33.33 | 33.33 | 30.67 | 23.90 | 0.123 | |||
| Physical limitations (0-100) | 24 | 16.67 | 33.33 | 22.92 | 22.42 | 25 | 33.33 | 33.33 | 32.67 | 24.76 | 0.156 | |||
| Social limitations (0-100) | 24 | 0.00 | 5.56 | 5.56 | 10.87 | 25 | 0.00 | 11.11 | 8.22 | 20.98 | 0.581 | |||
| Personal relationships (0-100) | 16 | 0.00 | 0.00 | 0.00 | 0.00 | 16 | 0.00 | 0.00 | 5.21 | 11.74 | ||||
| Emotions (0-100) | 24 | 11.11 | 22.22 | 12.50 | 14.40 | 25 | 11.11 | 22.22 | 16.44 | 20.06 | 0.435 | |||
| Sleep/energy (0-100) | 24 | 16.67 | 33.33 | 27.08 | 31.01 | 25 | 33.33 | 33.33 | 37.33 | 31.28 | 0.255 | |||
| Severity measures (0-100) | 24 | 25.00 | 16.67 | 26.39 | 17.66 | 25 | 33.33 | 25.00 | 37.33 | 20.99 | ||||
| Part III | ||||||||||||||
| Symptom severity scale (0-30) | 24 | 6.00 | 4.00 | 6.38 | 2.93 | 25 | 10.00 | 4.00 | 9.04 | 3.51 | ||||
| ICIQ-UI SF | Scale (0-21) | 24 | 4.50 | 4.00 | 5.38 | 2.83 | 25 | 9.00 | 5.00 | 7.76 | 4.08 | |||
| GSE-UI | Scale (0-120) | 24 | 94.50 | 31.00 | 89.13 | 23.86 | 25 | 67.00 | 34.00 | 69.08 | 25.46 | |||
| HADS | Anxiety scale (0-21) | 24 | 5.00 | 6.00 | 5.13 | 4.59 | 25 | 7.00 | 5.00 | 7.80 | 4.65 | |||
| Normal | 19 | 79.2% | 16 | 64.0% | 0.593 | |||||||||
| Mild | 2 | 8.3% | 4 | 16.0% | ||||||||||
| Moderate | 2 | 8.3% | 2 | 8.0% | ||||||||||
| Severe | 1 | 4.2% | 3 | 12.0% | ||||||||||
| Depression scale (0-21) | 24 | 2.00 | 3.50 | 3.08 | 3.28 | 25 | 3.00 | 3.00 | 3.44 | 3.92 | 0.732 | |||
| Normal | 21 | 87.5% | 22 | 88.0% | 0.720 | |||||||||
| Mild | 2 | 8.3% | 1 | 4.0% | ||||||||||
| Moderate | 1 | 4.2% | 1 | 4.0% | ||||||||||
| Severe | 0 | 0.0% | 0 | |||||||||||
T-tests for continuous variables and chi-square tests for categorical variables VAS Visual Analogue Scale, KHQ King’s Health Questionnaire, ICIQ-UI SF International Consultation on Incontinence Questionnaire – urinary incontinence short form, GSE-UI Geriatric Self-Efficacy index for urinary incontinence, HADS Hospital Anxiety and Depression Scale
Mean, standard error (SE) and p-values of pre-post intervention differences and treatment effect
| Variable | Dimensions | Baseline differencea | Follow-up differencea | Treatment effectc | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| ORb/Coef. | SE | ORb/Coef. | SE | ORb/Coef. | SE | |||||
| EQ-5D-5L | Mobility | |||||||||
| No/slight problem | ||||||||||
| Moderate/Severe/extreme problem | 1.33 | 0.92 | 0.675 | 0.57 | 0.45 | 0.481 | 0.32 | 0.33 | 0.267 | |
| Selfcare | ||||||||||
| No/slight problem | ||||||||||
| Moderate/Severe/extreme problem | ||||||||||
| Usual activities | ||||||||||
| No/slight problem | ||||||||||
| Moderate/Severe/extreme problem | 1.38 | 1.02 | 0.663 | 1.05 | 0.81 | 0.950 | 0.74 | 0.77 | 0.774 | |
| Pain & discomfort | ||||||||||
| No/slight problem | ||||||||||
| Moderate/Severe/extreme problem | 1.84 | 1.12 | 0.317 | 1.30 | 0.85 | 0.683 | 0.63 | 0.62 | 0.637 | |
| Anxiety & depression | ||||||||||
| No/slight problem | ||||||||||
| Moderate/Severe/extreme problem | 0.63 | 0.46 | 0.526 | 1.05 | 0.91 | 0.957 | 1.24 | 1.14 | 0.811 | |
| Index | 0.02 | 0.05 | 0.643 | 0.04 | 0.05 | 0.471 | 0.02 | 0.03 | 0.540 | |
| VAS | 7.27 | 6.35 | 0.258 | 5.54 | 4.66 | 0.240 | 3.82 | 4.51 | 0.402 | |
| KHQ | Part I | |||||||||
| General health perception (0-100) | 1.33 | 5.35 | 0.804 | -0.79 | 6.30 | 0.900 | -1.63 | 5.38 | 0.763 | |
| Incontinence impact (0-100) | -11.11 | 6.44 | -3.50 | 6.79 | 0.609 | 3.07 | 6.26 | 0.626 | ||
| Part II | ||||||||||
| Role limitations (0-100) | -13.19 | 6.66 | -10.53 | 6.71 | 0.123 | -1.06 | 4.96 | 0.831 | ||
| Physical limitations (0-100) | -7.75 | 6.17 | 0.216 | -9.75 | 6.76 | 0.156 | -3.82 | 4.96 | 0.446 | |
| Social limitations (0-100) | -7.42 | 5.64 | 0.195 | -2.67 | 4.80 | 0.581 | 1.66 | 3.61 | 0.648 | |
| Personal relationships (0-100) | -6.35 | 7.37 | 0.396 | -5.21 | 2.93 | -3.89 | 2.19 | |||
| Emotions (0-100) | -0.93 | 5.09 | 0.856 | -3.94 | 5.01 | 0.435 | -3.44 | 3.24 | 0.294 | |
| Sleep/energy (0-100) | -9.83 | 8.67 | 0.263 | -10.25 | 8.90 | 0.255 | -3.68 | 6.92 | 0.598 | |
| Severity measures (0-100) | -14.64 | 6.44 | -10.94 | 5.55 | -1.36 | 3.86 | 0.725 | |||
| Part III | ||||||||||
| Symptom severity scale (0-30) | -1.92 | 1.21 | 0.119 | -2.67 | 0.93 | -1.77 | 0.76 | |||
| ICIQ-UI SF | Scale (0-21) | -1.06 | 1.18 | 0.374 | -2.39 | 1.01 | -1.87 | 0.84 | ||
| GSE-UI | Scale (0-120) | 27.20 | 6.11 | 20.05 | 7.05 | -4.90 | 5.16 | 0.348 | ||
| HADS | Anxiety scale (0-21) | -0.44 | 1.38 | 0.755 | -2.68 | 1.32 | -2.31 | 0.66 | ||
| Normal | ||||||||||
| Ill | 0.92 | 0.53 | 0.879 | 0.47 | 0.31 | 0.245 | 0.34 | 0.28 | 0.188 | |
| Depression scale (0-21) | -0.21 | 1.05 | 0.840 | -0.36 | 1.03 | 0.732 | -0.17 | 0.46 | 0.715 | |
| Normal | ||||||||||
| Ill | 2.30 | 2.11 | 0.364 | 1.05 | 0.91 | 0.957 | 0.44 | 0.54 | 0.505 | |
VAS Visual Analogue Scale, KHQ King’s Health Questionnaire, ICIQ-UI SF International Consultation on Incontinence Questionnaire – urinary incontinence short form, GSE-UI Geriatric Self-Efficacy index for urinary incontinence, HADS Hospital Anxiety and Depression ScaleaDifference=intervention-control; bOR: odds ratio; cFor each outcome, analysis of covariance (ANCOVA) model with the baseline outcome was used to estimate the treatment effect
Fig. 1Mean (95 and 90% confidence intervals) of pre-post intervention differences and treatment effect for EQ-5D
Fig. 2Mean (95 and 90% confidence intervals) of pre-post intervention differences and treatment effect for EQ-5D utility and VAS scores
Fig. 3Mean (95 and 90% confidence intervals) of pre-post intervention differences and treatment effect for KHQ, Part I
Fig. 4Mean (95 and 90% confidence intervals) of pre-post intervention differences and treatment effect for KHQ, Part II
Fig. 5Mean (95 and 90% confidence intervals) of pre-post intervention differences and treatment effect for KHQ, Part III
Fig. 6Mean (95 and 90% confidence intervals) of pre-post intervention differences and treatment effect for ICIQ-UI SF
Fig. 7Mean (95 and 90% confidence intervals) of pre-post intervention differences and treatment effect for GSE-UI
Fig. 8Mean (95 and 90% confidence intervals) of pre-post intervention differences and treatment effect for HADS, Anxiety
Fig. 9Mean (95 and 90% confidence intervals) of pre-post intervention differences and treatment effect for HADS, Anxiety
Correlation between PGI-I and changes in outcomes within intervention group
| Mean change (SD) | PGI-I | Spearman's correlation | ||||||
|---|---|---|---|---|---|---|---|---|
| Very much worse | Much worse | A little worse | No change | A little better | Much better | Very much better | ||
| 0 (0%) | 0 (0%) | 4 (16.7) | 3 (12.5) | 9 (37.5) | 7 (29.2) | 1 (4.2) | ||
| EQ-5D-5L | ||||||||
| Index | NA | NA | 0.03 (0.10) | 0.08 (0.01) | 0.05 (0.09) | 0.05 (0.14) | 0.00 (.) | -0.05 |
| VAS | NA | NA | 2.50 (16.58) | 8.33 (23.63) | 13.89 (18.33) | 2.86 (14.39) | -15.00 (.) | -0.04 |
| KHQ | ||||||||
| Part I | ||||||||
| General health perception (0-100) | NA | NA | 12.50 (43.30) | 8.33 (14.43) | -8.33 (17.68) | -14.29 (13.36) | 25.00 (.) | -0.25 |
| Incontinence impact (0-100) | NA | NA | -8.33 (16.67) | 0.00 (33.33) | 7.41 (27.78) | -4.76 (12.60) | 0.00 (.) | 0.05 |
| Part II | ||||||||
| Role limitations (0-100) | NA | NA | -8.33 (9.62) | 5.56 (9.62) | -0.00 (18.63) | 2.38 (17.82) | 0.00 (.) | 0.15 |
| Physical limitations (0-100) | NA | NA | 8.33 (28.87) | 0.00 (16.67) | 1.85 (15.47) | -4.76 (8.13) | -16.67 (.) | -0.19 |
| Social limitations (0-100) | NA | NA | -5.56 (6.42) | 0.00 (0.00) | -0.62 (14.28) | -7.94 (12.36) | 0.00 (.) | -0.05 |
| Personal relationships (0-100) | NA | NA | -16.67 (16.67) | 0.00 (.) | 0.00 (0.00) | -6.67 (14.91) | 0.00 (.) | 0.29 |
| Emotions (0-100) | NA | NA | -11.11 (20.29) | 0.00 (0.00) | -3.70 (9.62) | -6.35 (8.74) | 22.22 (.) | 0.08 |
| Sleep/energy (0-100) | NA | NA | -4.17 (20.97) | -22.22 (9.62) | -7.41 (23.73) | -21.43 (20.89) | 50.00 (.) | -0.02 |
| Severity measures (0-100) | NA | NA | -12.50 (4.81) | -22.22 (17.35) | -3.70 (10.30) | -4.76 (13.49) | 0.00 (.) | 0.38* |
| Part III | ||||||||
| Symptom severity scale (0-30) | NA | NA | -1.25 (6.50) | 0.00 (4.36) | -1.89 (3.92) | -2.43 (3.78) | 0.00 (.) | -0.13 |
| ICIQ-UI SF | ||||||||
| Scale (0-21) | NA | NA | -2.75 (2.22) | -1.33 (4.51) | -3.89 (3.66) | -3.86 (4.34) | -1.00 (.) | -0.02 |
| GSE-UI | ||||||||
| Scale (0-120) | NA | NA | -15.00 (17.03) | 0.67 (11.02) | 8.78 (9.87) | 10.71 (15.64) | 4.00 (.) | 0.43** |
| HADS | ||||||||
| Anxiety scale (0-21) | NA | NA | -1.75 (0.96) | -0.67 (1.53) | -1.11 (1.96) | -4.14 (3.34) | 0.00 (.) | -0.22 |
| Depression scale (0-21) | NA | NA | -1.00 (1.63) | 0.33 (0.58) | -0.56 (1.88) | -0.86 (2.12) | 0.00 (.) | -0.02 |
PGI-I Patient Global Impression: Improvement, VAS Visual Analogue Scale, KHQ King’s Health Questionnaire, ICIQ-UI SF International Consultation on Incontinence Questionnaire – urinary incontinence short form, GSE-UI Geriatric Self-Efficacy index for urinary incontinence, HADS Hospital Anxiety and Depression Scale**p < 0.05; *p < 0.1